Liquid biopsy, initially for lung and breast cancer patients, can rapidly match treatment to specific tumour

Thousands of cancer patients in England are to benefit from a DNA blood test that saves lives by fast-tracking them on to personalised treatments.

In a world-first, the NHS will offer patients with lung and breast cancer – two of the most common forms of the disease – a liquid biopsy that detects tiny fragments of tumour DNA.